Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Patient Access to Cancer Treatment Act of 2013
Client: 340B HEALTH · Firm: 340B HEALTH
FY14 Labor-HHS Appropriations Bill, H.R. 2869, Orphan Drug Rule, ACA implementation, 340B Drug Discount Program Congressional Oversight
Medicare Patient Access to Cancer Treatment Act of 2013
Client: 340B HEALTH · Firm: 340B HEALTH
- The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2014 · second_quarter · Q2
FY14 Labor-HHS Appropriations Bill, H.R. 2869, Orphan Drug Rule, ACA implementation, 340B Drug Discount Program Congressional Oversight
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2014 · first_quarter · Q1
Source: Senate LDA
Medicare Patient Access to Cancer Treatment Act of 2013
Client: 340B HEALTH · Firm: 340B HEALTH
FY14 Labor-HHS Appropriations Bill, Medicare Part B Drug Reimbursement, H.R. 2869, Orphan Drug Rule, ACA implementation, SGR reform pay-fors, 340B Drug Discount Program Congressional Oversight
FY14 and FY 15 Labor-HHS Appropriations Bill, 340B Drug Discount Program Congressional Oversight, HRSA's expected 2014 Mega-Rule on 340B, cancer drug reimbursement, hospital reimbursement issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE
2013 · fourth_quarter · Q4
FY14 Labor-HHS Appropriations Bill, Medicare Part B Drug Reimbursement, H.R. 2869, Orphan Drug Rule, ACA implementation, SGR reform pay-fors, 340B Drug Discount Program Congressional Oversight
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · third_quarter · Q3
- The 340B Drug Discount program - Medicare Part B Drug Reimbursement, H.R. 2869 - Orphan Drug Rule, ACA implementation - SGR reform pay-fors
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · second_quarter · Q2
Discussing the importance of the 340B drug discount program and improving program oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE
2013 · first_quarter · Q1
Discussing the importance of the 340B drug discount program and improving program oversight.
Filing targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE